Chang VT - Search Results

1

Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia.

Sorrentino VG, Thota S, Gonzalez EA, Rameshwar P, Chang VT, Etchegaray JP. Sorrentino VG, et al. Among authors: chang vt. Pharmaceuticals (Basel). 2021 Jul 4;14(7):641. doi: 10.3390/ph14070641. Pharmaceuticals (Basel). 2021. PMID: 34358067 Free PMC article. Review.

2

Implication of CD44 in adhesion-mediated overproduction of TGF-beta and IL-1 in monocytes from patients with bone marrow fibrosis.

Rameshwar P, Chang VT, Gascón P. Rameshwar P, et al. Among authors: chang vt. Br J Haematol. 1996 Apr;93(1):22-9. doi: 10.1046/j.1365-2141.1996.4631004.x. Br J Haematol. 1996. PMID: 8611464

3

Systemic transforming growth factor-beta in patients with bone marrow fibrosis--pathophysiological implications.

Rameshwar P, Chang VT, Thacker UF, Gascón P. Rameshwar P, et al. Among authors: chang vt. Am J Hematol. 1998 Oct;59(2):133-42. doi: 10.1002/(sici)1096-8652(199810)59:2<133::aid-ajh6>3.0.co;2-z. Am J Hematol. 1998. PMID: 9766798 Free article.

4

Mimicry between neurokinin-1 and fibronectin may explain the transport and stability of increased substance P immunoreactivity in patients with bone marrow fibrosis.

Rameshwar P, Joshi DD, Yadav P, Qian J, Gascon P, Chang VT, Anjaria D, Harrison JS, Song X. Rameshwar P, et al. Among authors: chang vt. Blood. 2001 May 15;97(10):3025-31. doi: 10.1182/blood.v97.10.3025. Blood. 2001. PMID: 11342427 Free article.

5

Substance p-fibronectin-cytokine interactions in myeloproliferative disorders with bone marrow fibrosis.

Rameshwar P, Oh HS, Yook C, Gascon P, Chang VT. Rameshwar P, et al. Among authors: chang vt. Acta Haematol. 2003;109(1):1-10. doi: 10.1159/000067268. Acta Haematol. 2003. PMID: 12486316 Review.

6

Bone marrow failure following severe injury in humans.

Livingston DH, Anjaria D, Wu J, Hauser CJ, Chang V, Deitch EA, Rameshwar P. Livingston DH, et al. Ann Surg. 2003 Nov;238(5):748-53. doi: 10.1097/01.sla.0000094441.38807.09. Ann Surg. 2003. PMID: 14578739 Free PMC article.

7

Neurokinin receptors: relevance to the emerging immune system.

Kang HS, Trzaska KA, Corcoran K, Chang VT, Rameshwar P. Kang HS, et al. Among authors: chang vt. Arch Immunol Ther Exp (Warsz). 2004 Sep-Oct;52(5):338-47. Arch Immunol Ther Exp (Warsz). 2004. PMID: 15507875 Review.

8

Synergism between fibronectin and transforming growth factor-β1 in the production of substance P in monocytes of patients with myelofibrosis.

Chang VT, Yook C, Rameshwar P. Chang VT, et al. Leuk Lymphoma. 2013 Mar;54(3):631-8. doi: 10.3109/10428194.2012.722218. Epub 2012 Sep 11. Leuk Lymphoma. 2013. PMID: 22906243

9

NFĸB Targeting in Bone Marrow Mesenchymal Stem Cell-Mediated Support of Age-Linked Hematological Malignancies.

Sherman LS, Patel SA, Castillo MD, Unkovic R, Taborga M, Gergues M, Patterson S, Etchegaray JP, Jaloudi M, Hooda-Nehra A, Kra J, Rojas DP, Chang VT, Rameshwar P. Sherman LS, et al. Among authors: chang vt. Stem Cell Rev Rep. 2021 Dec;17(6):2178-2192. doi: 10.1007/s12015-021-10235-6. Epub 2021 Aug 19. Stem Cell Rev Rep. 2021. PMID: 34410592

10

Regional cancer pain syndromes.

Chang VT, Janjan N, Jain S, Chau C. Chang VT, et al. J Palliat Med. 2006 Dec;9(6):1435-53. doi: 10.1089/jpm.2006.9.1435. J Palliat Med. 2006. PMID: 17187551 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

145 results

Search Page